CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01093 CSPC PHARMA

Closed Hong Kong Special Administrative Region Establishment Day 06-30 16:08:07

6.970

-0.180

-2.52%

High7.220	Low6.850	Vol131.82M
Open7.060	D1 Closing7.150	Amplitude5.17%
Mkt Cap80.31B	Tradable Cap80.31B	Total Shares11.52B
T/O920.54M	T/O Rate1.14%	Tradable Shares11.52B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"CSPC PHARMA","latestPrice":6.97,"timestamp":1782806887004,"preClose":7.15,"halted":0,"volume":131819809,"delay":0,"changeRate":-0.025174825174825256,"floatShares":11522000000,"shares":11522000000,"eps":0.39239856477342244,"marketStatus":"Closed Hong Kong Special Administrative Region Establishment Day","change":-0.18,"latestTime":"06-30 16:08:07","open":7.06,"high":7.22,"low":6.85,"amount":920536511,"amplitude":0.051748,"askPrice":6.98,"askSize":120000,"bidPrice":6.97,"bidSize":242000,"shortable":3,"etf":0,"ttmEps":0.33023491809797184,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782955800000},"marketStatusCode":7,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":7.15,"dividendRate":0.043109,"openAndCloseTimeList":[[1782783000000,1782792000000],[1782795600000,1782806400000]],"volumeRatio":1.3578577445143423,"optionData":{"bulkOrders":[{"symbol":"CSP.HK","call":true,"expireDate":1790611200000,"strike":"9.00","timestamp":1782705114679,"price":0.3,"volume":400,"amount":240000,"type":"*"},{"symbol":"CSP.HK","call":true,"expireDate":1782662400000,"strike":"7.50","timestamp":1782702239687,"price":0.03,"volume":293,"amount":17580,"type":"*"}]},"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.5378,"impliedVolPercentile":0.5388},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"2647155554","title":"CSPC Pharmaceutical - Initiates Phase Iii Trial of Sys 6010 with Enlonstobart in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2647155554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647155554?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:07","pubTimestamp":1782828438,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN43210R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1226287792.SGD","IE00BZ08YS42.EUR","01093","LU1960683339.HKD","IE0008368742.USD","LU1226287875.USD","LU1993786604.SGD","LU0314109678.HKD","LU0067412154.USD","BK1191","LU2039709279.SGD","HK0000165453.HKD","LU0140636845.USD","IE00B543WZ88.USD","LU0501845795.SGD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU0315179316.USD","BK1515","LU1328277881.USD","IE00BZ08YT58.USD","LU1152091754.HKD","IE00B031HY20.USD","BK1521","IE0008369823.USD","LU0880133367.SGD","LU1226287529.USD","LU0326950275.SGD","LU1226288253.USD","LU1008478684.HKD","LU1152091168.USD","LU1226288170.HKD","LU1807302812.USD","IE00B5MMRT66.SGD","LU0072913022.USD","SG9999004220.SGD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536849","title":"CSPC Pharmaceutical Group Stock Falls 2.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536849","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647536849?lang=en_us&edition=fundamental","pubTime":"2026-06-30 16:33","pubTimestamp":1782808380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 2.5% to 6.97 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.6% to 22881.02.The stock's fall snapped a two-day winning streak.CSPC Pharmaceutical Group Ltd. closed 40% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock underperformed when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 1.8%, SSY Group Ltd. fell 1.9%, and United Laboratories International Holdings Ltd. fell 1.4%.Trading volume totaled 131.8 million shares, compared to the 50-day average of 92.3 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 30, 2026 04:33 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","IE00BZ08YT58.USD","BK1191","LU1008478684.HKD","LU1807302812.USD","LU0501845795.SGD","LU1993786604.SGD","BK1521","LU1226288170.HKD","LU0315179316.USD","LU0140636845.USD","IE0008368742.USD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1951186391.HKD","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1226287792.SGD","LU2039709279.SGD","IE00B543WZ88.USD","LU0314109678.HKD","SG9999004220.SGD","LU0072913022.USD","LU1226287529.USD","01093","LU1813983027.USD","LU0880133367.SGD","LU1960683339.HKD","LU1226287875.USD","LU1152091168.USD","LU1152091754.HKD","LU1328277881.USD","HK0000165453.HKD","LU1226288253.USD","BK1515","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189543018","title":"Movement Alert｜CSPC Pharmaceutical Falls 3.08% in Regular Trading, Pharmaceutical Sector Faces Broad Selling Pressure After Prior Session Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1189543018","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189543018?lang=en_us&edition=fundamental","pubTime":"2026-06-30 14:35","pubTimestamp":1782801340,"startTime":"0","endTime":"0","summary":"On June 30, CSPC Pharmaceutical fell 3.08% in regular trading, trading at HK$6.93/share, with turnover of HK$481 million. The decline comes amid uniform weakness across the pharmaceutical sector,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647327725","title":"Chinese Biopharma Stocks Rally as Investors Favor Healthcare over AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2647327725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647327725?lang=en_us&edition=fundamental","pubTime":"2026-06-29 17:33","pubTimestamp":1782725580,"startTime":"0","endTime":"0","summary":"Chinese biopharma stocks rallied on Monday, as investors moved away from artificial-intelligence stocks amid concerns over overstretched valuations.Shares of BeOne Medicines led gains among biopharma ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","CHAT","01877","AGIX","LU1303224171.USD","XBI","02315","01093","BK1502","AIPO","BK0216","LU1255011170.USD","IE00BZ08YS42.EUR","BK1189","BK0028","XLV","LU0140636845.USD","688180","IE00BPRC5H50.USD","BK1191","LU1008478684.HKD","BK0196","BK1583","01801","ARTY","LU1226287529.USD","LU1251922891.USD","BK0239","LU1807302812.USD","BK0012","LU1993786604.SGD","00241","BK4137","HCSG","LU2039709279.SGD","LABU","LU2328871848.SGD","603259","09637","LU0456827905.SGD","86618","LU0405327494.USD","LU0315179316.USD","BK1571","BK1161","06618","ISBC","BK4585","600276","LU1808992512.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647917324","title":"CSPC Pharmaceutical Group Stock Rallies 6.9% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2647917324","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647917324?lang=en_us&edition=fundamental","pubTime":"2026-06-29 16:30","pubTimestamp":1782721800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 6.9% to 7.15 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.6% to 23026.68.This was the stock's second consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 39% short of its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. rose 5.4%, SSY Group Ltd. rose 2.4%, and United Laboratories International Holdings Ltd. rose 3.9%.Trading volume totaled 156.4 million shares, compared to the 50-day average of 90.8 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 29, 2026 04:30 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0501845795.SGD","LU0140636845.USD","LU1152091168.USD","IE00B5MMRT66.SGD","LU1226288170.HKD","BK1521","LU0315179316.USD","IE0008369823.USD","LU1152091754.HKD","IE00BZ08YT58.USD","BK1515","IE00BZ08YS42.EUR","LU1993786604.SGD","LU0880133367.SGD","HK0000165453.HKD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1226287529.USD","IE00B543WZ88.USD","LU1328277881.USD","LU1226287792.SGD","LU1813983027.USD","LU1951186391.HKD","IE0008368742.USD","LU1807302812.USD","BK1191","LU0314109678.HKD","LU1960683339.HKD","LU0067412154.USD","01093","LU0072913022.USD","LU2039709279.SGD","LU1226287875.USD","SG9999004220.SGD","LU0326950275.SGD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183414506","title":"CSPC PHARMA Shares Surge Over 10% in Morning Trading as Key Phase III Trial Commences in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1183414506","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183414506?lang=en_us&edition=fundamental","pubTime":"2026-06-29 12:00","pubTimestamp":1782705635,"startTime":"0","endTime":"0","summary":"Shares of CSPC PHARMA (01093) surged more than 10% in morning trading. At the time of writing, the stock was up 10.61% to HK$7.40, with a turnover of HK$662 million. The company announced that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU0140636845.USD","IE00BZ08YS42.EUR","LU0067412154.USD","LU1960683339.HKD","SG9999004220.SGD","LU0880133367.SGD","LU1152091754.HKD","IE00B031HY20.USD","IE0008369823.USD","01093","LU1813983027.USD","LU1328277881.USD","BK1191","LU1993786604.SGD","LU1807302812.USD","LU0072913022.USD","LU1152091168.USD","LU0326950275.SGD","LU1008478684.HKD","BK1521","IE00BZ08YR35.GBP","LU0314109678.HKD","LU0501845795.SGD","LU1226287875.USD","LU2039709279.SGD","LU1226288170.HKD","LU1951186391.HKD","IE00B5MMRT66.SGD","HK0000165453.HKD","IE0008368742.USD","LU0315179316.USD","LU1226287792.SGD","LU1226287529.USD","IE00BZ08YT58.USD","LU1226288253.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148997308","title":"HK Movers | Hang Seng up More Than 2% Intraday, Led by CSPC PHARMA, INNOVENT BIO and Baidu","url":"https://stock-news.laohu8.com/highlight/detail?id=1148997308","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148997308?lang=en_us&edition=fundamental","pubTime":"2026-06-29 11:19","pubTimestamp":1782703144,"startTime":"0","endTime":"0","summary":"On Monday, the Hang Seng Index extended its intraday gains to 2%, with  $CSPC PHARMA(01093)$  surging over 10%,  $INNOVENT BIO(01801)$  climbing more than 8%, and Baidu advancing over 7%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09888","01093","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179003722","title":"Movement Alert｜CSPC Pharmaceutical Rises 3.29% in Regular Trading, Core ADC Pipeline SYS6010 Initiates Phase III Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1179003722","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179003722?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:05","pubTimestamp":1782698752,"startTime":"0","endTime":"0","summary":"On June 29, CSPC Pharmaceutical rose 3.29% in regular trading, trading at HKD 7.11/share, with turnover of HKD 204 million.On the news front, CSPC Pharmaceutical recently announced that its core ADC...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647477973","title":"CSPC Pharmaceutical Group (SEHK:1093) Wins Two China Drug Milestones As Valuation Looks About Right","url":"https://stock-news.laohu8.com/highlight/detail?id=2647477973","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647477973?lang=en_us&edition=fundamental","pubTime":"2026-06-29 08:16","pubTimestamp":1782692211,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (SEHK:1093) has drawn fresh investor attention after two drug developments in China, including approval of a quick dissolving albumin bound paclitaxel and regulatory acceptance of a new hypertension combination tablet.\nSee our latest analysis for CSPC Pharmaceutical Group.\nDespite these clinical milestones, CSPC Pharmaceutical Group’s recent share price momentum has been weak, with the 30 day share price return down 10.8% and the year to date share price return down...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/cspc-pharmaceutical-group-sehk1093-wins-two-china-drug-miles","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/cspc-pharmaceutical-group-sehk1093-wins-two-china-drug-miles","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0501845795.SGD","LU0140636845.USD","LU1152091168.USD","IE00B5MMRT66.SGD","LU1226288170.HKD","BK1521","LU0315179316.USD","IE0008369823.USD","LU1152091754.HKD","IE00BZ08YT58.USD","BK1515","IE00BZ08YS42.EUR","LU1993786604.SGD","LU0880133367.SGD","HK0000165453.HKD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1008478684.HKD","LU1226287529.USD","IE00B543WZ88.USD","LU1328277881.USD","LU1226287792.SGD","LU1813983027.USD","LU1951186391.HKD","IE0008368742.USD","LU1807302812.USD","BK1191","LU0314109678.HKD","LU1960683339.HKD","LU0067412154.USD","01093","LU0072913022.USD","LU2039709279.SGD","DCF","LU1226287875.USD","SG9999004220.SGD","LU0326950275.SGD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646735245","title":"CSPC Pharma Begins Phase III Trial of SYS6010 Combo for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2646735245","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646735245?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:10","pubTimestamp":1782475856,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical (HKG:1093) began a phase III study of SYS6010 in combination with enlonstobart in China.The drug is being tested for the treatment of non-small cell lung cancer, according to a Friday Hong Kong bourse filing.The first subject will be enrolled in the trial in July.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YT58.USD","01093","LU1152091168.USD","HK0000165453.HKD","IE00B031HY20.USD","IE00B543WZ88.USD","LU1226287875.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1960683339.HKD","LU1813983027.USD","LU1008478684.HKD","LU1152091754.HKD","LU1993786604.SGD","LU1951186391.HKD","LU0314109678.HKD","IE0008368742.USD","LU2039709279.SGD","BK1191","LU0067412154.USD","LU0315179316.USD","LU1226287529.USD","LU1226288253.USD","LU1328277881.USD","BK1521","LU0140636845.USD","IE00B5MMRT66.SGD","BK1515","BK4134","LU1807302812.USD","III","SG9999004220.SGD","LU1226288170.HKD","LU0501845795.SGD","LU0880133367.SGD","IE00BZ08YS42.EUR","LU0072913022.USD","IE0008369823.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118531837","title":"Trustee of CSPC PHARMA Acquires 4.4 Million Shares Under Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1118531837","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118531837?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:26","pubTimestamp":1782473170,"startTime":"0","endTime":"0","summary":"An announcement from CSPC PHARMA (HKEX: 01093) discloses that on June 26, 2026, the trustee of the company acted in accordance with the 2026 Share Award Scheme.The trustee purchased a total of 4.4...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287875.USD","01093","LU0880133367.SGD","LU0140636845.USD","LU1226287529.USD","LU1993786604.SGD","BK1191","IE00B5MMRT66.SGD","LU1152091168.USD","LU0067412154.USD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1328277881.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU1226287792.SGD","LU1960683339.HKD","HK0000165453.HKD","LU1813983027.USD","LU2039709279.SGD","LU1226288170.HKD","LU0326950275.SGD","SG9999004220.SGD","IE0008369823.USD","LU1807302812.USD","BK1521","LU1226288253.USD","LU0314109678.HKD","IE0008368742.USD","LU1008478684.HKD","LU1152091754.HKD","IE00BZ08YS42.EUR","BK1515","LU1951186391.HKD","LU0501845795.SGD","LU0315179316.USD","LU0072913022.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136016388","title":"CSPC Pharma: Trustee Acquires 4.40 Million Shares for 2026 Restricted Share Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1136016388","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136016388?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:25","pubTimestamp":1782473134,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (CSPC) disclosed that the designated trustee for its 2026 Restricted Share Award Scheme purchased 4.40 million shares on-market on 26 June 2026. The shares, acquired...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154358195","title":"CSPC PHARMA's Phase III Trial for Novel NSCLC Combination Therapy Launches in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1154358195","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154358195?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:06","pubTimestamp":1782468373,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (HKEX: 01093) has announced the official initiation in China of a Phase III clinical study for its drug candidate SYS6010 in combination with Enlangsuba monoclonal...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","LU0880133367.SGD","LU0140636845.USD","LU1226287875.USD","LU1807302812.USD","LU0314109678.HKD","IE0008369823.USD","BK1191","LU1226287529.USD","LU1960683339.HKD","LU1993786604.SGD","IE00BZ08YR35.GBP","LU1226288170.HKD","LU0067412154.USD","LU1813983027.USD","LU2039709279.SGD","SG9999004220.SGD","IE0008368742.USD","LU1152091168.USD","HK0000165453.HKD","01093","LU1152091754.HKD","LU0501845795.SGD","IE00B543WZ88.USD","LU1226288253.USD","LU0315179316.USD","LU1008478684.HKD","LU0072913022.USD","LU1951186391.HKD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU0326950275.SGD","BK1521","LU1226287792.SGD","LU1328277881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646401355","title":"CSPC Starts China Phase III Trial of Sys6010-enlonstobart Combo in Driver Gene-negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2646401355","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646401355?lang=en_us&edition=fundamental","pubTime":"2026-06-26 17:58","pubTimestamp":1782467913,"startTime":"0","endTime":"0","summary":"CSPC starts China Phase III trial of SYS6010-enlonstobart combo in driver gene-negative NSCLCCSPC Pharmaceutical launched a Phase III China study of SYS6010 with PD-1 drug enlonstobart in driver gene-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL11h4Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287529.USD","IE00BZ08YR35.GBP","HK0000165453.HKD","01093","IE00BZ08YT58.USD","LU0067412154.USD","LU1813983027.USD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU1226287875.USD","LU1226287792.SGD","LU0140636845.USD","LU0072913022.USD","LU1951186391.HKD","IE00B543WZ88.USD","IE0008369823.USD","LU0314109678.HKD","LU1226288170.HKD","LU0880133367.SGD","LU1960683339.HKD","LU1328277881.USD","BK1191","BK1515","IE00B5MMRT66.SGD","LU1152091168.USD","LU2039709279.SGD","SG9999004220.SGD","LU0315179316.USD","LU0501845795.SGD","IE00B031HY20.USD","LU1008478684.HKD","BK1521","LU1807302812.USD","LU1226288253.USD","LU1152091754.HKD","LU0326950275.SGD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646450334","title":"CSPC Pharma Trustee Buys 5,950,000 Shares for Hk$39.6 Million Under 2026 Award Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2646450334","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646450334?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:22","pubTimestamp":1782458544,"startTime":"0","endTime":"0","summary":"CSPC Pharma trustee buys 5,950,000 shares for HK$39.6 million under 2026 award schemeCSPC Pharmaceutical adopted its 2026 restricted share award scheme, triggering on-market buying by the scheme trust","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL9qwDrD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1813983027.USD","LU0072913022.USD","LU1993786604.SGD","IE0008368742.USD","LU1328277881.USD","LU0501845795.SGD","LU1226288253.USD","IE00BZ08YR35.GBP","01093","LU0314109678.HKD","LU1226287792.SGD","LU1152091168.USD","LU1152091754.HKD","LU0315179316.USD","LU1807302812.USD","IE00BZ08YT58.USD","LU1008478684.HKD","LU1226287875.USD","LU0140636845.USD","LU1226288170.HKD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU1226287529.USD","SG9999004220.SGD","LU1960683339.HKD","BK1191","BK1515","IE00B031HY20.USD","IE0008369823.USD","LU0880133367.SGD","LU0326950275.SGD","LU2039709279.SGD","IE00B543WZ88.USD","BK1521","LU0067412154.USD","LU1951186391.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109507293","title":"Movement Alert｜CSPC Pharmaceutical Group Declines 3.09% in Regular Trading, Trading at HKD 6.57","url":"https://stock-news.laohu8.com/highlight/detail?id=1109507293","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109507293?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:10","pubTimestamp":1782353432,"startTime":"0","endTime":"0","summary":"On June 25, CSPC Pharmaceutical Group (01093.HK) declined 3.09% in regular trading, trading at HKD 6.57/share, with turnover of HKD 108 million.Within the Pharmaceuticals sector where CSPC...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645893723","title":"CSPC Pharmaceutical Group Stock Climbs 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2645893723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645893723?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:32","pubTimestamp":1782289920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rallied 1.5% to 6.79 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.3% to 23412.18.This was the stock's sixth consecutive day of losses.CSPC Pharmaceutical Group Ltd. closed 42% below its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 0.9%, SSY Group Ltd. rose 1.8%, and United Laboratories International Holdings Ltd. rose 0.1%.Trading volume totaled 102.9 million shares, compared to the 50-day average of 88.6 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 24, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","LU1152091168.USD","BK1515","BK1521","LU0072913022.USD","LU0140636845.USD","LU1008478684.HKD","LU1226287792.SGD","IE0008369823.USD","LU0315179316.USD","LU1813983027.USD","LU1951186391.HKD","BK1191","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1152091754.HKD","IE0008368742.USD","IE00B031HY20.USD","LU1226287529.USD","LU1226287875.USD","LU1960683339.HKD","LU2039709279.SGD","IE00BZ08YS42.EUR","LU1226288253.USD","LU0880133367.SGD","01093","LU1328277881.USD","SG9999004220.SGD","IE00B543WZ88.USD","LU0326950275.SGD","LU0501845795.SGD","LU0314109678.HKD","LU1807302812.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU0067412154.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197555622","title":"Movement Alert｜CSPC Pharmaceutical Group Rises 3.14% in Regular Trading, Chairman Nearly HK$100 Million Share Purchase Coupled with Subsidiary Re-filing for HKEX Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1197555622","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197555622?lang=en_us&edition=fundamental","pubTime":"2026-06-24 11:12","pubTimestamp":1782270764,"startTime":"0","endTime":"0","summary":"On June 24, CSPC Pharmaceutical Group rose 3.14% in regular trading, trading at HK$6.91/share, with turnover of HK$377 million. Multiple positive catalysts converged to boost market confidence.On the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645183874","title":"CSPC Pharma trustee buys 2,900,000 shares for HK$19.84 million under 2026 share award scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2645183874","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645183874?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:04","pubTimestamp":1782212652,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical introduced a 2026 restricted share award scheme. A trustee bought 2,900,000 shares in the market on June 23.Average purchase price HK$ 6.84. Total consideration about HK$ 19.84 million, excluding transaction costs.The purchase equals about 0.03% of shares outstanding. Trustee holdings under the 2026 scheme rose to 35,828,000 shares, about 0.31%.A separate trustee for the 2018 share award scheme holds 117,000,000 shares on trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSPC Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 23, 2026, and is solely responsible for the information ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL4X2ztn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328277881.USD","IE00B543WZ88.USD","LU1960683339.HKD","LU0880133367.SGD","LU1226288170.HKD","IE00B031HY20.USD","LU1008478684.HKD","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU1226287529.USD","LU0140636845.USD","LU2039709279.SGD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU1152091754.HKD","IE0008369823.USD","LU0072913022.USD","LU0326950275.SGD","LU1993786604.SGD","LU1807302812.USD","LU1226287792.SGD","LU0501845795.SGD","LU0314109678.HKD","LU1152091168.USD","SG9999004220.SGD","LU1813983027.USD","IE00B5MMRT66.SGD","LU1226288253.USD","LU0315179316.USD","LU0067412154.USD","01093","LU1226287875.USD","BK1191","IE0008368742.USD","BK1515","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166354160","title":"Trustee of CSPC PHARMA Acquires 5.8 Million Shares Under Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1166354160","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166354160?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:12","pubTimestamp":1782126757,"startTime":"0","endTime":"0","summary":"An announcement from CSPC PHARMA (HKEX: 01093) discloses that on June 22, 2026, the trustee of the company's 2026 Share Award Scheme purchased a total of 5.8 million shares in the market.The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1813983027.USD","IE00B543WZ88.USD","LU0314109678.HKD","IE0008369823.USD","LU0315179316.USD","IE0008368742.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU1960683339.HKD","LU1226287875.USD","LU1328277881.USD","LU1951186391.HKD","BK1515","LU1993786604.SGD","LU1226287529.USD","SG9999004220.SGD","LU1152091754.HKD","IE00B5MMRT66.SGD","LU0326950275.SGD","LU1807302812.USD","LU1226287792.SGD","LU0072913022.USD","LU1008478684.HKD","BK1521","LU1226288170.HKD","IE00BZ08YR35.GBP","LU0501845795.SGD","LU0140636845.USD","LU1152091168.USD","LU0880133367.SGD","LU1226288253.USD","HK0000165453.HKD","LU2039709279.SGD","BK1191","LU0067412154.USD","IE00BZ08YT58.USD","01093"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.0419},{"period":"1month","weight":-0.0499},{"period":"3month","weight":-0.2592},{"period":"6month","weight":-0.1546},{"period":"1year","weight":-0.0603},{"period":"ytd","weight":-0.1546}],"compareEarnings":[{"period":"1week","weight":-0.0195},{"period":"1month","weight":-0.0914},{"period":"3month","weight":-0.0954},{"period":"6month","weight":-0.1073},{"period":"1year","weight":-0.0495},{"period":"ytd","weight":-0.1073}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.75,"avgChangeRate":0.094313},{"month":3,"riseRate":0.46875,"avgChangeRate":0.017543},{"month":4,"riseRate":0.59375,"avgChangeRate":0.057684},{"month":5,"riseRate":0.59375,"avgChangeRate":0.042479},{"month":6,"riseRate":0.3125,"avgChangeRate":0.001853},{"month":7,"riseRate":0.375,"avgChangeRate":0.00927},{"month":8,"riseRate":0.4375,"avgChangeRate":0.009887},{"month":9,"riseRate":0.5,"avgChangeRate":0.000334},{"month":10,"riseRate":0.5625,"avgChangeRate":0.01001},{"month":11,"riseRate":0.46875,"avgChangeRate":0.006831},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013329}],"exchange":"SEHK","name":"CSPC PHARMA","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CSPC PHARMA(01093) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CSPC PHARMA,01093,CSPC PHARMA股票,CSPC PHARMA股票老虎,CSPC PHARMA股票老虎国际,CSPC PHARMA行情,CSPC PHARMA股票行情,CSPC PHARMA股价,CSPC PHARMA股市,CSPC PHARMA股票价格,CSPC PHARMA股票交易,CSPC PHARMA股票购买,CSPC PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CSPC PHARMA(01093) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}